202 related articles for article (PubMed ID: 611665)
1. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
[No Abstract] [Full Text] [Related]
2. Iron chelating therapy in thalassemia: current problems.
Russo G
Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
[No Abstract] [Full Text] [Related]
3. Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.
Hussain MA; Green N; Flynn DM; Hoffbrand AV
Lancet; 1977 May; 1(8019):977-9. PubMed ID: 67469
[TBL] [Abstract][Full Text] [Related]
4. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
Cartei G; Cazzavillan M; Chisesi T; Battista R; Barbui T; Dini E
Minerva Med; 1978 Mar; 69(13):811-21. PubMed ID: 643223
[No Abstract] [Full Text] [Related]
5. Vitamin C and iron.
Nienhuis AW
N Engl J Med; 1981 Jan; 304(3):170-1. PubMed ID: 7442737
[No Abstract] [Full Text] [Related]
6. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
[No Abstract] [Full Text] [Related]
7. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
Krüger N; Kijewski H; König R; Tillmann W; Schröter W
Dtsch Med Wochenschr; 1984 Nov; 109(44):1682-5. PubMed ID: 6489181
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of hemosiderosis with deferoxamine].
Strohmeyer G; Stremmel W
Dtsch Med Wochenschr; 1984 Nov; 109(44):1669-70. PubMed ID: 6489179
[No Abstract] [Full Text] [Related]
9. Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.
Kaung DT
J Iowa Med Soc; 1965 Jun; 55(6):312-6. PubMed ID: 5835475
[No Abstract] [Full Text] [Related]
10. Iron metabolism and iron chelation in the thalassaemia disorders.
Pippard MJ
Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383
[No Abstract] [Full Text] [Related]
11. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
Girot R; Thévenin M; Bouveret JP; Jeannel F; Rymer JC
Arch Fr Pediatr; 1980 Apr; 37(4):241-7. PubMed ID: 7406638
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
[No Abstract] [Full Text] [Related]
13. Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.
Schafer AI; Rabinowe S; Le Boff MS; Bridges K; Cheron RG; Dluhy R
Arch Intern Med; 1985 Jul; 145(7):1217-21. PubMed ID: 3925909
[TBL] [Abstract][Full Text] [Related]
14. Treatment of iron overload in adults with continuous parenteral desferrioxamine.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Am J Med; 1977 Dec; 63(6):958-66. PubMed ID: 605917
[TBL] [Abstract][Full Text] [Related]
15. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
Tillmann W; König R; Schröder K; Schröter W
Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
[No Abstract] [Full Text] [Related]
16. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
Sidi Y; Shaklai M; Liban E; Pinkhas J
Isr J Med Sci; 1981 May; 17(5):348-51. PubMed ID: 7263191
[TBL] [Abstract][Full Text] [Related]
17. [The effect of desferrioxamine on the treatment of transfusion hemosiderosis--with special reference to the method of its administration (authors' transl)].
Fujiyama N; Nakazawa K
Rinsho Ketsueki; 1977 Dec; 18(12):1393-400. PubMed ID: 604522
[No Abstract] [Full Text] [Related]
18. Improvement of erythropoiesis during treatment with deferiprone in a patient with myelofibrosis and transfusional hemosiderosis.
Smeets ME; Vreugdenhil G; Holdrinet RS
Am J Hematol; 1996 Mar; 51(3):243-4. PubMed ID: 8619408
[No Abstract] [Full Text] [Related]
19. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
20. Improved pituitary gonadotrophin response in adult transfusional haemosiderosis following desferrioxamine treatment.
Waters AK
Horm Metab Res; 1982 Jan; 14(1):55. PubMed ID: 7061039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
